Hiroshi Teranaka

Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7

T. Mitsuhashi, M. Murata, K. Kameyama, 2020, HemaSphere.

Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2020, International Journal of Hematology.

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

E. Yamazaki, H. Nakajima, Kenji Matsumoto, 2017 .

Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis

N. Horita, H. Namkoong, Y. Kirino, 2023, Journal of hematology.